gvtcx

EU Notified Body designated under Regulation (EU) 2017/746 (IVDR)

NHS Blood and Transplant Published 6 May 2025 Find a Tender

key details

Value£160,000 (£192,000 inc. VAT)
Statuscomplete
Category (CPV) 72225000 +1 more
Deadline24 Apr 2025
Procedureopen
OCIDocds-h6vhtk-04e9b4

Award

SupplierValueDateStatus
not named · · cancelled

description

NHS Blood and Transplant (NHSBT) is seeking to engage with an EU Notified Body designated under Regulation (EU) 2017/746 (IVDR) to undertake conformity assessment of in vitro diagnostic medical devices (IVDs) and appropriate surveillance of legacy IVDs. NHSBT is a Special Health Authority that provides a blood and transplantation service to the NHS, looking after blood donation services in England and transplant services across the UK. NHSBT Reagents is a specialist department within NHSBT that designs, manufactures and distributes in vitro diagnostic medical devices for transfusion and transplantation investigations including blood grouping control reagents. NHSBT’s current EU Notified Body has not been designated under the IVDR and we require the services of an alternative EU Notified Body for conformity assessment and CE-certification of IVDs under the IVDR, and for appropriate surveillance of legacy IVDs (i.e. IVDs that are covered by a certificate issued by a Notified Body in accordance with Directive 98/79/EC (IVDD) and which comply with the conditions set out in Article 110 (3c) of the IVDR). It is imperative that NHSBT is able to lodge a formal application for conformity assessment and sign a written agreement with an alternative EU Notified Body in accordance with deadlines set out in the Article 110 (3c) point (e) and Article 110 (3c) point (f) of the IVDR, respectively. This will enable NHSBT to benefit from the extended transitional period provided for in the IVDR, as amended by Regulation (EU) 2024/1860. The device risk class, IVDR transitional deadlines and number of devices / products are summarised in the tender documents. The EU Notified Body’s designation must cover the scope of designation applicable to the IVDs manufactured by NHSBT which is summarised as follows: • NBOG Codes that apply to legacy devices; IVD0101, IVD0102, IVD0302, MDS7210. • IVDR Codes that apply to the IVDR devices; IVR0101, IVR0102, IVR0103, IVR0104, IVR0105, IVR0106, IVS1004, IVT2006, IVT2008, IVT2009, IVT2011, IVP3001, IVP3006 (note: not all codes apply to all devices). NHSBT’s requirements are summarised below: • Surveillance assessment of legacy devices during the transitional period. • Assessment of NHSBT’s Quality Management System. • Undertake announced and unannounced audits. • Conformity assessment and CE-certification of NHSBT’s IVDs. • Surveillance assessment of IVDR CE-certified IVDs (following initial certification). • Batch / product verification for Class D devices. • Validate the Summary of Safety and Performance for Class D and C devices. • Assess and approve (or reject) proposed/planned substantial changes to NHSBT Reagents product range, products or Quality Management System.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

4 notices published against this procurement.

PublishedTypeRegimeNotice
5 Mar 2025 Preliminary market engagement (UK2) Procurement Act 2023 008003-2025
5 Mar 2025 Preliminary market engagement (UK2) Procurement Act 2023 008004-2025
27 Mar 2025 Tender notice (UK4) Procurement Act 2023 011644-2025
6 May 2025 Procurement termination (UK12) Procurement Act 2023 019139-2025

more from NHS Blood and Transplant

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.